Reversible Sympathetic Overactivity in Hypertensive Patients with Primary Aldosteronism

Abstract

These data provide the first evidence in humans that APA is accompanied by reversible sympathetic overactivity, which may contribute to the accelerated hypertensive target organ disease in this condition.